I
Immunovant, Inc. (IMVT)
NMS – Real Time Price. Currency in USD
28.65
-0.41 (-1.41%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
28.65
-0.41 (-1.41%)
At close: May 12, 2026, 4:00 PM EDT
Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren’s disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
| Name | Position |
|---|---|
| Dr. Eric Venker M.D., Pharm.D. | CEO & Director |
| Dr. Frank M. Torti M.B.A., M.D. | Executive Chairperson of the Board |
| Dr. Jay S. Stout M.S., Ph.D. | Chief Technology Officer |
| Mr. Andy Deig M.B.A. | Senior Vice President of Strategic Finance |
| Mr. Christopher A. Van Tuyl Esq., J.D. | Chief Legal Officer & Corporate Secretary |
| Ms. Becky Merlina | Senior VP & Global Head of Quality |
| Date | Type | Document |
|---|---|---|
| 2026-02-06 | 10-Q | imvt-20251231.htm |
| 2025-12-12 | 8-K | d68980d8k.htm |
| 2025-11-21 | 8-K | imvt-20251121.htm |
| 2025-11-10 | 8-K | imvt-20251110.htm |
| 2025-09-03 | 8-K | imvt-20250903.htm |
| 2025-08-28 | 8-K | imvt-20250827.htm |
| 2025-08-11 | 8-K | imvt-20250811.htm |
| 2025-08-11 | 10-Q | imvt-20250630.htm |
| 2025-07-29 | 8-K | imvt-20250728.htm |
| 2025-07-09 | DEFA14A | defa14aadditionalmaterials.htm |
| Ms. Christine Blodgett | Senior Vice President of Human Resources |
| Ms. Julie Kirschling | Senior Vice President of Program & Alliance Management |
| Ms. Sheetal Patel M.B.A., M.D., M.S. | Senior Vice President of Clinical Development |
| Ms. Yan Zheng M.S., Ph.D. | Senior Vice President of Biostatistics, Programming & Data Management |